IMO-3100

· Idera Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMO-3100, covering 2017-11-13 to 2017-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]